Results 81 to 90 of about 82,196 (246)

A Thematic Framework for Analyzing Large-scale Self-reported Social Media Data on Opioid Use Disorder Treatment Using Buprenorphine Product [PDF]

arXiv
Background: One of the key FDA-approved medications for Opioid Use Disorder (OUD) is buprenorphine. Despite its popularity, individuals often report various information needs regarding buprenorphine treatment on social media platforms like Reddit. However, the key challenge is to characterize these needs.
arxiv  

Practices and Outcomes Associated With Sublingual Buprenorphine Use in a Critically Ill Population

Critical Care Explorations
IMPORTANCE:. Buprenorphine for opioid use disorder (OUD) is commonly used in the outpatient setting with increasing use in hospitalized patients. However, there is limited literature describing its use in critically ill populations. OBJECTIVES:.
Denis J. Vanini, PharmD, BCCCP, Jenna M. Corvelli, PharmD, BCCCP, Kaylee M. Maynard, PharmD, BCCCP, Stephen H. Rappaport, PharmD, BCCCP, Gina Grasso, PharmD, Raquel Jones, PharmD, BCPS, Nicole M. Acquisto, PharmD, FASHP, FCCM, FCCP, BCCCP, Rachel F. Schult, PharmD, DABAT   +7 more
doaj   +1 more source

Commentary on Gibson et al. (2017): Gestational age and the severity of neonatal abstinence syndrome [PDF]

, 2017
No abstract ...
Allocco, Bier, Desai, Dryden, Gibson, Hodgson, Jones, Kocherlakota, Liu, Mactier, Maeda, McGlone, McGlone, Noormohammadi, Steinhorn, Yuan   +15 more
core   +1 more source

THE ANIMAL PHARMACOLOGY OF BUPRENORPHINE, AN ORIPAVINE ANALGESIC AGENT [PDF]

, 1977
A. Cowan, John C. Doxey, E J R Harry
openalex   +1 more source

Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims

Drug and Alcohol Dependence Reports, 2023
Background: As the overdose crisis continues in the U.S. and Canada, opioid use disorder (OUD) treatment outcomes for people with co-occurring psychiatric disorders are not well characterized.
Kevin Y Xu, Vivien Huang, Arthur Robin Williams, Caitlin E Martin, Alexander R. Bazazi, Richard A. Grucza   +5 more
doaj  

Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS). [PDF]

, 2019
Neonatal abstinence syndrome is defined by signs and symptoms of withdrawal that infants develop after intrauterine maternal drug exposure. All infants with documented in utero opioid exposure, or a high pre-test probability of exposure should have ...
Kraft, W. K., Mangat, A. K., Schmölzer, G. M.   +2 more
core   +1 more source

Randomised trial comparing buprenorphine and diamorphine for chest pain in suspected myocardial infarction. [PDF]

, 1979
Marie J. Hayes, Alan Fraser, J R Hampton
openalex   +1 more source

Low-dose buprenorphine initiation during pregnancy: a case report

AJOG Global Reports
Buprenorphine is recommended for pregnant patients with opioid use disorder. Traditional buprenorphine initiation requires moderate withdrawal symptoms to prevent precipitating withdrawal.
Shivania Reddy, BSc, Caitlin E. Martin, MD, MPH, FACOG, FASAM   +1 more
doaj  

The relative risk of fatal poisoning by methadone or buprenorphine within the wider population of England and Wales

BMJ Open, 2015
Objective To examine the population-wide overdose risk emerging from the prescription of methadone and buprenorphine for opioid substitution treatment in England and Wales.Design Retrospective administrative data study.Setting National databases for ...
Dave Marteau, Rebecca McDonald, Kamlesh Patel   +2 more
doaj   +1 more source

Haemodynamic effects of buprenorphine after heart surgery [PDF]

, 1979
D J Coltart, D Thompson, N Naqui
openalex   +1 more source